ALBIOREX, INC. – Trademark Portfolio
Entity Type: 03
ALBIOREX, INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HUMALLAGEN. The owner is based in OLDSMAR, FL.
300 STATE STREET
OLDSMAR, FL 34677
Showing of trademarks Trademarks
Trademark Classifications
ALBIOREX, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ALBIOREX, INC. have?
ALBIOREX, INC. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does ALBIOREX, INC. file in?
ALBIOREX, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ALBIOREX, INC.'s most well-known trademarks?
ALBIOREX, INC.'s registered trademark portfolio includes well-known marks such as HUMALLAGEN. These are among 1 currently registered trademark in the portfolio.
What is ALBIOREX, INC.'s trademark registration success rate?
ALBIOREX, INC. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.